Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2013, Article ID 647476, 13 pages
http://dx.doi.org/10.1155/2013/647476
Clinical Study

Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database

1Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN 46285, USA
2Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London SW1W 9SZ, UK
3Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
4London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK

Received 1 July 2013; Revised 10 October 2013; Accepted 15 October 2013

Academic Editor: Kenji Hashimoto

Copyright © 2013 Meghan E. Jones et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Meghan E. Jones, Giedra Campbell, Deven Patel, et al., “Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database,” Cardiovascular Psychiatry and Neurology, vol. 2013, Article ID 647476, 13 pages, 2013. https://doi.org/10.1155/2013/647476.